INVITRO ANTIBACTERIAL ACTIVITY OF RIFAXIMIN AGAINST CLOSTRIDIUM-DIFFICILE, CAMPYLOBACTER-JEJUNII AND YERSINIA SPP
- 1 January 1987
- journal article
- research article
- Vol. 13 (8) , 483-488
Abstract
Fifty-four isolates of Campylobacter jejunii, 91 isolates of Yersinia spp. and 56 isolates of Clostridium difficile, recovered from stools of patients with diarrhoea or other intestinal disturbances and from stools of asymptomatic patients receiving antibiotic therapy, were tested in vitro for susceptibility to rifaximin, rifampicin and neomycin. The in vitro antibacterial activities were found to be comparable against the aerobic bacterium; on the contrary, against microaerophilic and anaerobic bacteria rifaximin and rifampicin were much more effective than neomycin.This publication has 5 references indexed in Scilit:
- Passive hemagglutination technique for serotyping Campylobacter fetus subsp. jejuni on the basis of soluble heat-stable antigensJournal of Clinical Microbiology, 1980
- Cytotoxicity Assay in Antibiotic-Associated ColitisThe Journal of Infectious Diseases, 1979
- SENSITIVITY TO CHEMOTHERAPEUTICS OF YERSINIA-ENTEROCOLITICA STRAINS1979
- An Assessment of Yersinia enterocolitica and Its Presence in FoodsJournal of Food Protection, 1977
- Yersinia enterocolitica‐LIKE ORGANISMS FROM VACUUM‐PACKAGED BEEF AND LAMBJournal of Food Science, 1976